Complement activation by sulfonated poly(ethylene glycol)-acrylate copolymers through alternative pathway. 2006

Hong Seok Jang, and Kyu Eun Ryu, and Woong Shick Ahn, and Heung Jae Chun, and Hyung Dal Park, and Ki Dong Park, and Young Ha Kim
Department of Therapeutic Radiology, Uijeongbu St. Mary's Hospital, College of Medicine, Catholic University, Uijeongbu 480-130, Korea.

Previously, novel poly(ethylene glycol) (PEG) and sulfonated PEG acrylate (PEG-SO(3)A/OA) copolymers were prepared as coating and/or blending materials for biomedical applications. Surfaces modified with copolymers exhibited increased anti-coagulation properties and decreased plasma adsorption level due to increased hydrophilic properties and reorientation characteristics of PEG/PEG-SO(3)A chains in water phase. As continuation study, anti-complement effects of PEG-SO(3)/OA copolymers were investigated in vitro, and compared with those of low-density polyethylene (LDPE) and PEG/OA. C3 activation by PEG-SO(3)/OA samples was lower than that by PEG/OA samples, which was attributed to decreased surface nucleophile level of samples. PEG-SO(3)/OA samples increased inhibition of Bb production, resulting in decreased C5 activation. Owing to reduced activations of C3 and C5, PEG-SO(3)/OA samples markedly decreased SC5b-9 levels in plasma.

UI MeSH Term Description Entries
D008422 Materials Testing The testing of materials and devices, especially those used for PROSTHESES AND IMPLANTS; SUTURES; TISSUE ADHESIVES; etc., for hardness, strength, durability, safety, efficacy, and biocompatibility. Biocompatibility Testing,Biocompatible Materials Testing,Hemocompatibility Testing,Testing, Biocompatible Materials,Testing, Hemocompatible Materials,Hemocompatibility Testings,Hemocompatible Materials Testing,Materials Testing, Biocompatible,Materials Testing, Hemocompatible,Testing, Biocompatibility,Testing, Hemocompatibility,Testing, Materials,Testings, Biocompatibility
D011092 Polyethylene Glycols Polymers of ETHYLENE OXIDE and water, and their ethers. They vary in consistency from liquid to solid depending on the molecular weight indicated by a number following the name. They are used as SURFACTANTS, dispersing agents, solvents, ointment and suppository bases, vehicles, and tablet excipients. Some specific groups are NONOXYNOLS, OCTOXYNOLS, and POLOXAMERS. Macrogols,Polyoxyethylenes,Carbowax,Macrogol,Polyethylene Glycol,Polyethylene Oxide,Polyethyleneoxide,Polyglycol,Glycol, Polyethylene,Glycols, Polyethylene,Oxide, Polyethylene,Oxides, Polyethylene,Polyethylene Oxides,Polyethyleneoxides,Polyglycols,Polyoxyethylene
D003170 Complement Pathway, Alternative Complement activation initiated by the interaction of microbial ANTIGENS with COMPLEMENT C3B. When COMPLEMENT FACTOR B binds to the membrane-bound C3b, COMPLEMENT FACTOR D cleaves it to form alternative C3 CONVERTASE (C3BBB) which, stabilized by COMPLEMENT FACTOR P, is able to cleave multiple COMPLEMENT C3 to form alternative C5 CONVERTASE (C3BBB3B) leading to cleavage of COMPLEMENT C5 and the assembly of COMPLEMENT MEMBRANE ATTACK COMPLEX. Alternative Complement Pathway,Properdin Pathway,Alternative Complement Activation Pathway,Complement Activation Pathway, Alternative
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000179 Acrylates Derivatives of acrylic acid (the structural formula CH2
D001672 Biocompatible Materials Synthetic or natural materials, other than DRUGS, that are used to replace or repair any body TISSUES or bodily function. Biomaterials,Bioartificial Materials,Hemocompatible Materials,Bioartificial Material,Biocompatible Material,Biomaterial,Hemocompatible Material,Material, Bioartificial,Material, Biocompatible,Material, Hemocompatible
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D015936 Complement C5a The minor fragment formed when C5 convertase cleaves C5 into C5a and COMPLEMENT C5B. C5a is a 74-amino-acid glycopeptide with a carboxy-terminal ARGININE that is crucial for its spasmogenic activity. Of all the complement-derived anaphylatoxins, C5a is the most potent in mediating immediate hypersensitivity (HYPERSENSITIVITY, IMMEDIATE), smooth MUSCLE CONTRACTION; HISTAMINE RELEASE; and migration of LEUKOCYTES to site of INFLAMMATION. C5a Complement,Complement 5a,Complement Component 5a,C5a, Complement,Complement, C5a,Component 5a, Complement
D015938 Complement Membrane Attack Complex A product of COMPLEMENT ACTIVATION cascade, regardless of the pathways, that forms transmembrane channels causing disruption of the target CELL MEMBRANE and cell lysis. It is formed by the sequential assembly of terminal complement components (COMPLEMENT C5B; COMPLEMENT C6; COMPLEMENT C7; COMPLEMENT C8; and COMPLEMENT C9) into the target membrane. The resultant C5b-8-poly-C9 is the "membrane attack complex" or MAC. Complement Complex C5b-9,Membrane Attack Complex,C 5b-9,C5b-8-poly-C9,C5b-9,Cytolytic Terminal Complement Complex,Terminal Complement Complex,C5b 8 poly C9,Complement Complex C5b 9,Complement Complex, Terminal,Complex, Terminal Complement
D020099 Coated Materials, Biocompatible Biocompatible materials usually used in dental and bone implants that enhance biologic fixation, thereby increasing the bond strength between the coated material and bone, and minimize possible biological effects that may result from the implant itself. Surface-Coated Materials,Biocompatible Coated Materials,Materials, Biocompatible Coated,Materials, Surface-Coated,Surface Coated Materials

Related Publications

Hong Seok Jang, and Kyu Eun Ryu, and Woong Shick Ahn, and Heung Jae Chun, and Hyung Dal Park, and Ki Dong Park, and Young Ha Kim
October 2000, Colloids and surfaces. B, Biointerfaces,
Hong Seok Jang, and Kyu Eun Ryu, and Woong Shick Ahn, and Heung Jae Chun, and Hyung Dal Park, and Ki Dong Park, and Young Ha Kim
March 2002, Journal of biotechnology,
Hong Seok Jang, and Kyu Eun Ryu, and Woong Shick Ahn, and Heung Jae Chun, and Hyung Dal Park, and Ki Dong Park, and Young Ha Kim
November 2009, Australian journal of chemistry,
Hong Seok Jang, and Kyu Eun Ryu, and Woong Shick Ahn, and Heung Jae Chun, and Hyung Dal Park, and Ki Dong Park, and Young Ha Kim
December 2008, Molecular immunology,
Hong Seok Jang, and Kyu Eun Ryu, and Woong Shick Ahn, and Heung Jae Chun, and Hyung Dal Park, and Ki Dong Park, and Young Ha Kim
January 2023, Gels (Basel, Switzerland),
Hong Seok Jang, and Kyu Eun Ryu, and Woong Shick Ahn, and Heung Jae Chun, and Hyung Dal Park, and Ki Dong Park, and Young Ha Kim
September 1998, Archives of biochemistry and biophysics,
Hong Seok Jang, and Kyu Eun Ryu, and Woong Shick Ahn, and Heung Jae Chun, and Hyung Dal Park, and Ki Dong Park, and Young Ha Kim
January 2014, PloS one,
Hong Seok Jang, and Kyu Eun Ryu, and Woong Shick Ahn, and Heung Jae Chun, and Hyung Dal Park, and Ki Dong Park, and Young Ha Kim
November 2011, Colloids and surfaces. B, Biointerfaces,
Hong Seok Jang, and Kyu Eun Ryu, and Woong Shick Ahn, and Heung Jae Chun, and Hyung Dal Park, and Ki Dong Park, and Young Ha Kim
March 1995, Biomaterials,
Hong Seok Jang, and Kyu Eun Ryu, and Woong Shick Ahn, and Heung Jae Chun, and Hyung Dal Park, and Ki Dong Park, and Young Ha Kim
March 2012, The journal of physical chemistry. B,
Copied contents to your clipboard!